J. Safra Asset Management’s Novo Nordisk NVO Stock Holding History

J. Safra Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.5K	Sell	428 -38	-8%	-$1.63K	﹤0.01%	322
2026 Q1	$17.1K	Hold	466	–	–	﹤0.01%	322
2025 Q4	$23.7K	Buy	+466	New	+$23.8K	﹤0.01%	312
2024 Q3	–	Sell	-968	Closed	-$138K	–	316
2024 Q2	$138K	Buy	968 +634	+190%	+$84K	0.01%	78
2024 Q1	$42.9K	Buy	334 +293	+715%	+$34.9K	﹤0.01%	95
2023 Q4	$4.24K	Buy	+41	New	+$4.05K	﹤0.01%	111
2016 Q3	–	Sell	-4,730	Closed	-$127K	–	211
2016 Q2	$127K	Buy	+4,730	New	+$130K	0.21%	45

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

J. Safra Asset Management's NVO Position: Q2 2026 in Review

J. Safra Asset Management reduced its Novo Nordisk (NVO) stake by 8.2% in Q2 2026, selling an estimated $1.63K and leaving 428 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

J. Safra Asset Management first reported a position in NVO in Q2 2016 and has held it in 7 quarters since. The position peaked at $138K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

J. Safra Asset Management held 428 shares of Novo Nordisk worth $20.5K as of Q2 2026.
J. Safra Asset Management sold 38 Novo Nordisk shares in Q2 2026, an estimated $1.63K.
Novo Nordisk made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #322 holding.
J. Safra Asset Management first reported a position in Novo Nordisk in Q2 2016 and has held it in 7 quarters since.
J. Safra Asset Management's Novo Nordisk position peaked at $138K in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.